42 results on '"Gearry, Richard B."'
Search Results
2. Descriptive Epidemiology of Pediatric Inflammatory Bowel Disease in Oceania: A Systematic Review and Meta-Analysis
3. Comparison of gastrointestinal landmarks using the gas‐sensing capsule and wireless motility capsule
4. Editorial: measuring disease severity in inflammatory bowel disease—the whole is greater than the sum of its parts. Authors' reply
5. The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a more complicated disease course
6. Editorial: brain‐gut research needs objective measures of disease activity and mental disorders—authors’ reply
7. The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease—results from the Stress, Anxiety and Depression with Disease Activity (SADD) Study
8. Assessment of Disease-related Knowledge Among Children With Inflammatory Bowel Disease and their Family Using IBD-KID2: Evaluating Tool Generalizability
9. Editorial: IBD medications during the COVID‐19 pandemic—are they safe to use?
10. COVID‐19–related personal product shortages are associated with psychological distress in people living with gastrointestinal disorders: A cross‐sectional survey
11. Editorial: social distancing during the COVID-19 pandemic - IBD patients cannot stay at home forever
12. Development and Validation of a Self‐management Skills Assessment Tool for Children With Inflammatory Bowel Disease
13. Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic
14. Low FODMAP diet in children and adolescents with functional bowel disorder: A clinical case note review
15. Editorial: better outcomes for Crohn's disease-more than just the drugs?
16. Central Sensitization Inventory Mediates the Relationship Between Inflammatory Bowel Disease Activity and Worse Musculoskeletal Pain Experiences
17. Response pattern analysis of IBD‐KID: A knowledge assessment tool for children with inflammatory bowel disease
18. Letter: low FODMAP diet-directions for future research
19. Low-FODMAP Diet Is Associated With Improved Quality of Life in IBS Patients-A Prospective Observational Study
20. Validation of the inflammatory bowel disease disability index for self-report and development of an item-reduced version
21. Serologic antibodies in relation to outcome in postoperative Crohn's disease
22. Fecal biomarkers in inflammatory bowel disease
23. Osteoprotegerin: A novel biomarker for inflammatory bowel disease and gastrointestinal carcinoma
24. Treat to target-what is realistic in Australian practice today?
25. Introduction
26. Biosimilar and innovator anti-Tumour Necrosis Factor (TNF) or lymphocyte trafficking blockade: Which one to select?
27. Inflammatory bowel disease risk and the environment: Where to next?
28. Smoking behaviour modifies IL23r -associated disease risk in patients with Crohn's disease
29. Inflammatory bowel disease in Asia: The start of the epidemic?
30. Predictors for developing intestinal failure in patients with Crohn's disease
31. Rescue therapy for steroid refractory acute severe ulcerative colitis: More choice, better outcomes?
32. Allopurinol might improve response to azathioprine and 6-mercaptopurine by correcting an unfavorable metabolite ratio
33. Optimizing thiopurine therapy: More weight to the metabolite argument
34. Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: An Australian and New Zealand experience
35. Population-based epidemiology study of autoimmune hepatitis: A disease of older women?
36. Azathioprine and allopurinol: A two-edged interaction
37. Population‐based cases control study of inflammatory bowel disease risk factors
38. Biologics for inflammatory bowel diseases in the Asia-Pacific: Can we afford to use them, can we afford not to?
39. Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs
40. Two cases of thiopurine methyltransferase (TPMT) deficiency ? a lucky save and a near miss with azathioprine
41. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease
42. Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.